We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

EU Agency Probes Safety Of Pfizer’s Champix

Law360 (December 17, 2007, 12:00 AM EST) -- The European Union’s medicine watchdog has opened an investigation into the safety of Pfizer Inc.’s Champix after alarming reports suggested risks of depression and suicide in patients using the anti-smoking treatment.

The European Medicines Agency, which authorizes drugs for the EU, asked Pfizer on Friday to turn over more information about the occurrences of depression and suicide in patients treated with Champix.

During a meeting this month, the agency said there was "a need to update the product information for Champix to warn doctors and patients...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.